RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: endometriosis
Accession: DOID:289
browse the term
Definition: A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
Synonyms: exact_synonym: ENDO1; ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1; Endometrioma; Endometriomas; Endometrioses
primary_id: MESH:D004715 ; RDO:0005488
alt_id: OMIM:131200
xref: ICD10CM:N80 ; ICD10CM:N80.9 ; ICD9CM:617 ; NCI:C3014
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abcc4
ATP binding cassette subfamily C member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25446850
NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
G
Abcc9
ATP binding cassette subfamily C member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 4:176,806,098...176,928,540
Ensembl chr 4:176,805,431...176,922,424
G
Abi3bp
ABI family member 3 binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr11:46,206,932...46,422,791
Ensembl chr11:46,208,075...46,369,577
G
Acta2
actin alpha 2, smooth muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
G
Akr1b1
aldo-keto reductase family 1 member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25446850
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
G
Akr1c2
aldo-keto reductase family 1, member C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21232532
NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
G
Akr1c3
aldo-keto reductase family 1, member C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21232532 PMID:25446850
NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
G
Ang
angiogenin
ISO
RGD
PMID:14748845 , PMID:15236995
RGD:2325705 , RGD:6892724
NCBI chr15:28,022,926...28,028,636
G
Ankh
ANKH inorganic pyrophosphate transport regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 2:80,131,563...80,256,948
Ensembl chr 2:80,131,563...80,256,954
G
Ankrd1
ankyrin repeat domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 1:254,726,985...254,745,673
Ensembl chr 1:254,726,969...254,735,548
G
Ano4
anoctamin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 7:29,492,017...30,025,587
Ensembl chr 7:29,492,016...29,701,721
G
Ar
androgen receptor
no_association
ISO
RGD
PMID:15120698
RGD:1578684
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
G
Areg
amphiregulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
G
Arhgap28
Rho GTPase activating protein 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 9:116,057,229...116,222,440
Ensembl chr 9:116,058,610...116,222,440
G
Arnt
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IDA
RGD
PMID:23406865
RGD:7257718
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcl2
BCL2, apoptosis regulator
treatment
ISO IDA
protein:increased expression:endometrium
RGD
PMID:17693084 , PMID:25937801 , PMID:23406865
RGD:2293018 , RGD:11353846 , RGD:7257718
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l1
Bcl2-like 1
treatment
IDA
RGD
PMID:25937801
RGD:11353846
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Birc5
baculoviral IAP repeat-containing 5
IMP
RGD
PMID:18386577
RGD:2293122
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Bmp7
bone morphogenetic protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 3:170,879,972...170,955,820
Ensembl chr 3:170,879,973...170,955,399
G
Brd8
bromodomain containing 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr18:27,375,645...27,423,989
Ensembl chr18:27,398,688...27,424,090
G
C1r
complement C1r
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 4:157,126,060...157,136,825
Ensembl chr 4:157,125,998...157,136,829
G
Ccl1
C-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30579999
NCBI chr10:69,534,976...69,537,836
Ensembl chr10:69,534,933...69,537,882
G
Ccl11
C-C motif chemokine ligand 11
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30579999 , PMID:18595729
RGD:2307108
NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:peritoneal fluid (human)
RGD
PMID:15005786
RGD:11528566
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccl22
C-C motif chemokine ligand 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30579999
NCBI chr19:10,674,189...10,681,145
Ensembl chr19:10,674,189...10,681,145
G
Ccl5
C-C motif chemokine ligand 5
IEP
mRNA:increased expression:endometrium (human)
RGD
PMID:18595729
RGD:2307108
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
G
Ccne2
cyclin E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 5:24,434,077...24,446,406
Ensembl chr 5:24,434,872...24,446,406
G
Cd226
CD226 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr18:86,299,392...86,394,772
Ensembl chr18:86,299,463...86,394,765
G
Cd36
CD36 molecule
ISO
mRNA, protein:decreased expression:macrophage
RGD
PMID:19606481
RGD:6893501
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
G
Cd55
CD55 molecule (Cromer blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
G
Cfd
complement factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 7:12,634,216...12,635,939
Ensembl chr 7:12,634,216...12,635,943
G
Cldn1
claudin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr11:77,815,216...77,830,373
Ensembl chr11:77,815,181...77,830,416
G
Cnih3
cornichon family AMPA receptor auxiliary protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr13:99,663,150...99,770,625
Ensembl chr13:99,663,150...99,770,625
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056
G
Cops2
COP9 signalosome subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 3:118,109,394...118,137,125
Ensembl chr 3:118,109,406...118,137,191
G
Cpm
carboxypeptidase M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 7:60,654,350...60,714,620
Ensembl chr 7:60,654,350...60,714,620
G
Csf1
colony stimulating factor 1
ISO
protein:increased expression:peritoneal fluid (human)
RGD
PMID:22365076
RGD:38500240
NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560
G
Cxcl13
C-X-C motif chemokine ligand 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30579999
NCBI chr14:15,253,146...15,258,221
Ensembl chr14:15,253,125...15,258,207
G
Cxcl14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr17:9,109,731...9,117,754
Ensembl chr17:9,109,731...9,117,750
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30579999
NCBI chr14:17,228,832...17,233,743
Ensembl chr14:17,228,856...17,234,712
G
Cyb5a
cytochrome b5 type A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr18:81,694,818...81,726,821
Ensembl chr18:81,694,808...81,726,821
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18815356 PMID:21958689 , PMID:8550748 , PMID:23406865
RGD:7257715 , RGD:7257718
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
RGD
PMID:18849443
RGD:5147674
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
G
Dcstamp
dendrocyte expressed seven transmembrane protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 7:78,725,173...78,756,160
Ensembl chr 7:78,649,875...78,650,906 Ensembl chr 7:78,649,875...78,650,906
G
Ddx5
DEAD-box helicase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr10:94,979,759...94,988,461
Ensembl chr10:94,980,928...94,988,461
G
Depp1
DEPP1, autophagy regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 4:148,780,330...148,784,566
Ensembl chr 4:148,782,479...148,784,562
G
Dicer1
dicer 1 ribonuclease III
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 6:128,388,084...128,453,234
Ensembl chr 6:128,388,053...128,434,183
G
Dio2
iodothyronine deiodinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 6:114,475,156...114,489,443
Ensembl chr 6:114,476,142...114,476,723
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 1:248,952,896...248,956,579
Ensembl chr 1:248,895,738...248,898,607 Ensembl chr 1:248,895,738...248,898,607
G
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:decreased expression:endometrium:
RGD
PMID:21316665
RGD:9588653
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
G
Dnmt3a
DNA methyltransferase 3 alpha
ISO
mRNA:increased expression:endometrium:
RGD
PMID:17081533
RGD:9588669
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
G
Dnmt3b
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:endometrium:
RGD
PMID:17081533
RGD:9588669
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
G
Dusp1
dual specificity phosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
G
Ebag9
estrogen receptor binding site associated, antigen, 9
ISO
protein:decreased expression:endometrium
RGD
PMID:16112719
RGD:2289850
NCBI chr 7:83,564,563...83,582,516
Ensembl chr 7:83,564,563...83,582,508
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Egr1
early growth response 1
IEP
mRNA, protein:increased expression:ovary
RGD
PMID:23427178
RGD:10395305
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
G
Elavl1
ELAV like RNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20889954
NCBI chr12:2,461,502...2,502,432
Ensembl chr12:2,461,502...2,502,432
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 1:21,748,201...21,813,205
Ensembl chr 1:21,748,261...21,813,371
G
Errfi1
ERBB receptor feedback inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 5:167,951,564...167,966,011
Ensembl chr 5:167,952,728...167,966,009
G
Esr1
estrogen receptor 1
ISO
RGD
PMID:16500359
RGD:1580337
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Esr2
estrogen receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17625110 , PMID:15618247
RGD:5509040
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
G
Fam180a
family with sequence similarity 180, member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 4:62,845,054...62,860,361
Ensembl chr 4:62,844,971...62,860,446
G
Fbln1
fibulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 7:126,096,793...126,176,468
Ensembl chr 7:126,096,793...126,176,468
G
Fbn1
fibrillin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120
G
Fgfr2
fibroblast growth factor receptor 2
no_association
ISO
DNA:SNPs mRNA:increased expression:ovary, epithelial cell
RGD
PMID:18285324 , PMID:17482184
RGD:2301190 , RGD:2301191
NCBI chr 1:200,590,951...200,696,946
Ensembl chr 1:200,590,953...200,696,928
G
Fkbp5
FKBP prolyl isomerase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020
G
Fmo2
flavin containing dimethylaniline monoxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr13:80,752,526...80,775,264
Ensembl chr13:80,755,058...80,775,264
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23284138
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Foxp3
forkhead box P3
severity
ISO
RGD
PMID:22541024
RGD:38501099
NCBI chr X:15,753,175...15,768,648
Ensembl chr X:15,753,175...15,768,522
G
Gc
GC, vitamin D binding protein
severity
ISO
RGD
PMID:18334925
RGD:5509874
NCBI chr14:20,267,023...20,302,577
Ensembl chr14:20,266,891...20,302,581
G
Ghrh
growth hormone releasing hormone
ISO
mRNA:decreased expression:ovary
RGD
PMID:11163834
RGD:2301425
NCBI chr 3:153,449,124...153,468,794
Ensembl chr 3:153,449,125...153,468,794
G
Gper1
G protein-coupled estrogen receptor 1
ISO
protein:decreased expression:endometrium (mouse) protein:increased expression:endometrium, cytoplasm (human)
RGD
PMID:32152908 , PMID:22520060
RGD:39938861 , RGD:39939083
NCBI chr12:17,309,122...17,315,267
Ensembl chr12:17,309,834...17,311,112
G
Gpx3
glutathione peroxidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642 PMID:21063030
NCBI chr10:40,247,436...40,255,423
Ensembl chr10:40,247,436...40,255,422
G
Greb1
growth regulating estrogen receptor binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23104006
NCBI chr 6:41,932,941...42,002,770
Ensembl chr 6:41,932,244...42,002,819
G
Hbegf
heparin-binding EGF-like growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr18:29,330,302...29,340,185
Ensembl chr18:29,329,764...29,340,403
G
Hdac1
histone deacetylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 5:147,716,664...147,743,723
Ensembl chr 5:147,716,664...147,743,723
G
Hdac2
histone deacetylase 2
treatment
IEP ISO
protein:decreased expression:ectopic endometrium, dorsal root ganglion: CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541 , PMID:20884991
RGD:9590244
NCBI chr20:43,084,870...43,108,198
Ensembl chr20:43,084,870...43,108,198
G
Hdac3
histone deacetylase 3
ISS
OMIM:131200
MouseDO
NCBI chr18:31,073,057...31,094,347
Ensembl chr18:31,073,058...31,094,303
G
Hs3st3b1
heparan sulfate-glucosamine 3-sulfotransferase 3B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr10:50,369,097...50,402,584
Ensembl chr10:50,366,952...50,402,616
G
Hsd17b1
hydroxysteroid (17-beta) dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18815356
NCBI chr10:88,987,558...88,989,758
Ensembl chr10:88,987,558...88,989,757
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18815356 PMID:21232532
NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891
G
Ido1
indoleamine 2,3-dioxygenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr16:72,216,326...72,228,098
Ensembl chr16:72,216,326...72,228,098
G
Ifng
interferon gamma
ISO
mRNA:increased expression:colon
RGD
PMID:29477012
RGD:14974258
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Ifngr1
interferon gamma receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 1:15,062,380...15,080,815
Ensembl chr 1:15,062,432...15,080,907
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
G
Igfbp1
insulin-like growth factor binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr14:87,448,716...87,453,783
Ensembl chr14:87,448,692...87,453,785
G
Igfbp6
insulin-like growth factor binding protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 7:143,749,385...143,754,018
Ensembl chr 7:143,749,221...143,754,054
G
Ihh
Indian hedgehog signaling molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 9:82,208,223...82,214,440
Ensembl chr 9:82,208,223...82,214,440
G
Il10
interleukin 10
treatment
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30579999 , PMID:21665488
RGD:11049494
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il15
interleukin 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr19:23,542,606...23,624,366
Ensembl chr19:23,542,889...23,554,594
G
Il1r1
interleukin 1 receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642 PMID:21063030
NCBI chr 9:46,962,291...47,038,139
Ensembl chr 9:46,962,288...47,036,670
G
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
G
Impa2
inositol monophosphatase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr18:63,016,577...63,050,123
Ensembl chr18:63,016,577...63,047,781
G
Itga2
integrin subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 2:46,996,904...47,097,011
Ensembl chr 2:47,000,323...47,096,961
G
Itgb1
integrin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr19:61,677,512...61,725,537
Ensembl chr19:61,677,542...61,725,535
G
Itgb3bp
integrin subunit beta 3 binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 5:118,476,410...118,541,928
Ensembl chr 5:118,476,430...118,673,780
G
Itgb8
integrin subunit beta 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 6:147,089,280...147,172,846
Ensembl chr 6:147,094,097...147,172,813
G
Kdr
kinase insert domain receptor
IEP
mRNA:increased expression:endometrium
RGD
PMID:20056215
RGD:5135061
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Klf13
Kruppel-like factor 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 1:124,772,596...124,803,363
Ensembl chr 1:124,772,596...124,803,363
G
Klf9
Kruppel-like factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 1:240,908,483...240,933,198
Ensembl chr 1:240,908,483...240,933,198
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23284138
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Lamb1
laminin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 6:50,528,796...50,596,593
Ensembl chr 6:50,528,823...50,596,079
G
Lmod1
leiomodin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr13:52,147,099...52,189,835
Ensembl chr13:52,147,555...52,190,228
G
Lrrk2
leucine-rich repeat kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 7:132,857,311...133,018,549
Ensembl chr 7:132,857,628...133,018,584
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 8:119,290,416...119,313,261
Ensembl chr 8:119,290,416...119,313,261
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
IEP
mRNA:increased expression:uterus
RGD
PMID:17845203
RGD:2303708
NCBI chr 5:16,526,058...16,642,648
Ensembl chr 5:16,526,058...16,642,648
G
Maoa
monoamine oxidase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr X:6,554,698...6,620,722
Ensembl chr X:6,554,698...6,620,722
G
Maob
monoamine oxidase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr X:6,430,694...6,533,520
Ensembl chr X:6,430,594...6,533,534
G
Mdk
midkine
ISO
RGD
PMID:15734764
RGD:1581202
NCBI chr 3:80,841,003...80,843,895
Ensembl chr 3:80,841,005...80,842,916
G
Med1
mediator complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr10:86,101,560...86,145,271
Ensembl chr10:86,103,600...86,144,880
G
Med14
mediator complex subunit 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr X:10,964,035...11,082,403
Ensembl chr X:10,963,809...11,082,565
G
Med16
mediator complex subunit 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 7:12,619,739...12,632,241
Ensembl chr 7:12,542,713...12,632,298
G
Med17
mediator complex subunit 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 8:13,522,257...13,835,302
Ensembl chr 8:13,819,563...13,835,168
G
Med4
mediator complex subunit 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr15:55,406,543...55,416,816
Ensembl chr15:55,406,543...55,416,815
G
Mettl7a
methyltransferase like 7A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 7:141,973,447...142,021,344
Ensembl chr 7:141,973,553...141,981,432
G
Mir21
microRNA 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
G
Mmp2
matrix metallopeptidase 2
IEP
mRNA:increased expression:endometrium
RGD
PMID:20056200
RGD:2325695
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp9
matrix metallopeptidase 9
IEP
mRNA:increased expression:endometrium
RGD
PMID:20085636
RGD:2325792
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Mta1
metastasis associated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 6:137,911,302...137,950,066
Ensembl chr 6:137,924,293...137,950,075
G
Mta2
metastasis associated 1 family, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 1:225,140,863...225,149,584
Ensembl chr 1:225,140,863...225,149,583
G
Mylip
myosin regulatory light chain interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr17:19,682,040...19,703,681
Ensembl chr17:19,682,040...19,703,681
G
Ncoa1
nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 6:28,677,563...28,931,844
Ensembl chr 6:28,677,540...28,931,843
G
Ncoa6
nuclear receptor coactivator 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 3:150,919,317...150,990,391
Ensembl chr 3:150,919,317...150,960,030
G
Ncor1
nuclear receptor co-repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr10:48,629,121...48,772,890
Ensembl chr10:48,629,121...48,772,890
G
Ndnf
neuron-derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 4:96,528,830...96,565,780
G
Nedd4l
NEDD4 like E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr18:60,392,376...60,719,720
Ensembl chr18:60,392,376...60,719,720
G
Nefm
neurofilament medium
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr15:44,855,307...44,860,604
Ensembl chr15:44,855,310...44,860,604
G
Nfkbia
NFKB inhibitor alpha
IEP
RGD
PMID:23954358
RGD:10413877
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr15:8,730,871...8,757,165
Ensembl chr15:8,730,871...8,757,165
G
Nr2c1
nuclear receptor subfamily 2, group C, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 7:35,069,807...35,122,810
Ensembl chr 7:35,069,814...35,122,796
G
Nr2c2
nuclear receptor subfamily 2, group C, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 4:124,005,287...124,030,349
Ensembl chr 4:124,005,280...124,030,349
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 1:131,447,671...131,465,749
Ensembl chr 1:131,448,447...131,460,473
G
Nr2f6
nuclear receptor subfamily 2, group F, member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr16:19,769,968...19,777,414
Ensembl chr16:19,769,968...19,777,414
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr19:34,408,275...34,761,003
Ensembl chr19:34,448,289...34,752,695
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr 7:142,899,358...142,920,216
Ensembl chr 7:142,905,758...142,920,216
G
Nr5a1
nuclear receptor subfamily 5, group A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17519303
NCBI chr 3:22,998,900...23,020,441
Ensembl chr 3:22,999,616...23,020,441
G
Nrp1
neuropilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr19:61,332,351...61,486,166
Ensembl chr19:61,332,351...61,485,858
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
ISO
mRNA, protein:increased expression:spinal ganglia, uterus
RGD
PMID:21385399
RGD:5684532
NCBI chr 2:187,143,568...187,160,373
Ensembl chr 2:187,143,568...187,160,373
G
Ntrk3
neurotrophic receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 1:139,890,537...140,262,503
Ensembl chr 1:139,890,560...140,262,503
G
Olfm4
olfactomedin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21048224
NCBI chr15:62,384,263...62,429,450
Ensembl chr15:62,406,873...62,429,449
G
Osr2
odd-skipped related transciption factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 7:74,047,820...74,055,096
Ensembl chr 7:74,047,814...74,055,256
G
Pappa1
pappalysin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 5:80,919,932...81,153,904
Ensembl chr 5:80,920,568...81,150,940
G
Pax2
paired box 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22473392
NCBI chr 1:264,493,579...264,585,073
Ensembl chr 1:264,504,591...264,583,329
G
Pgr
progesterone receptor
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642 PMID:21232532 , PMID:16126772 , PMID:21166214
RGD:1601277 , RGD:7248704
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
G
Pla2g2a
phospholipase A2 group IIA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25446850
NCBI chr 5:157,282,650...157,285,295
Ensembl chr 5:157,282,669...157,285,328
G
Plk1
polo-like kinase 1
ISO
mRNA, protein:increased expression
RGD
PMID:18353325
RGD:2299937
NCBI chr 1:192,115,990...192,125,969
Ensembl chr 1:192,115,966...192,125,989
G
Plxnc1
plexin C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 7:35,848,083...36,000,969
Ensembl chr 7:35,850,398...36,000,906
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11925390
NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
G
Prlr
prolactin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 2:60,131,410...60,325,686
Ensembl chr 2:60,131,776...60,325,692
G
Ptger2
prostaglandin E receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19407222
NCBI chr15:19,336,029...19,349,759
Ensembl chr15:19,338,175...19,350,210
G
Ptger4
prostaglandin E receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19407222
NCBI chr 2:54,951,625...54,966,470
Ensembl chr 2:54,952,821...54,963,448
G
Ptges
prostaglandin E synthase
ISO
mRNA, protein:increased expression:epithelial cell
RGD
PMID:17295901
RGD:2300079
NCBI chr 3:9,727,408...9,738,752
Ensembl chr 3:9,727,408...9,738,752
G
Ptgfr
prostaglandin F receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25446850
NCBI chr 2:257,005,813...257,039,036
Ensembl chr 2:257,005,829...257,038,105
G
Ptgs2
prostaglandin-endoperoxide synthase 2
treatment
IMP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD
PMID:25446850 , PMID:20056215 , PMID:23406865
RGD:5135061 , RGD:7257718
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Ptk2
protein tyrosine kinase 2
ISO
RGD
PMID:17543958
RGD:2292555
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
ISO
RGD
PMID:20070289
RGD:6484710
NCBI chr 2:206,342,066...206,390,348
Ensembl chr 2:206,342,066...206,390,348
G
Rarb
retinoic acid receptor, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr15:9,915,223...10,262,599
Ensembl chr15:10,120,206...10,262,599
G
Rasgrp1
RAS guanyl releasing protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 3:108,984,029...109,044,420
Ensembl chr 3:108,984,029...109,044,420
G
Rasl11a
RAS-like family 11 member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr12:9,986,150...9,990,284
Ensembl chr12:9,985,928...9,990,284
G
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr14:59,657,738...59,865,427
Ensembl chr14:59,658,935...59,735,450
G
Rgs4
regulator of G-protein signaling 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr13:88,054,817...88,061,108
Ensembl chr13:88,054,817...88,061,108
G
Rorb
RAR-related orphan receptor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 1:234,252,757...234,442,597
Ensembl chr 1:234,252,757...234,435,839
G
RT1-Db1
RT1 class II, locus Db1
severity
ISO
DNA:SNP: :rs660895 (human)
RGD
PMID:20797713
RGD:5147572
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
G
Runx1
RUNX family transcription factor 1
IEP
mRNA:increased expression:endometrium
RGD
PMID:17845203
RGD:2303708
NCBI chr11:32,765,147...33,003,061
Ensembl chr11:32,769,165...33,003,021
G
Rxfp1
relaxin family peptide receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 2:178,402,411...178,520,213
Ensembl chr 2:178,399,274...178,521,038
G
Scgb3a1
secretoglobin, family 3A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr10:35,133,561...35,134,868
Ensembl chr10:35,133,252...35,135,466
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 2:53,105,912...53,116,198
Ensembl chr 2:53,109,684...53,114,858
G
Sell
selectin L
IEP
mRNA:increased expression:endometrium
RGD
PMID:17845203
RGD:2303708
NCBI chr13:82,369,820...82,387,774
Ensembl chr13:82,369,493...82,387,631
G
Serpinf1
serpin family F member 1
treatment
ISO IEP
human protein in a rat model protein:decreased expression:endometrium (rat)
RGD
PMID:23466670 , PMID:22975116
RGD:8590225 , RGD:8638001
NCBI chr10:62,241,750...62,254,145
Ensembl chr10:62,241,756...62,254,287
G
Slc16a6
solute carrier family 16, member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr10:97,733,701...97,758,723
Ensembl chr10:97,735,548...97,756,521
G
Slc1a1
solute carrier family 1 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 1:246,955,017...247,035,159
Ensembl chr 1:246,954,980...247,037,056
G
Slc20a1
solute carrier family 20 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 3:121,725,204...121,739,160
Ensembl chr 3:121,725,859...121,739,173
G
Slc40a1
solute carrier family 40 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 9:52,819,451...52,830,461
Ensembl chr 9:52,894,365...52,912,293
G
Slc7a8
solute carrier family 7 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr15:33,369,245...33,428,942
Ensembl chr15:33,369,216...33,428,973
G
Smpdl3a
sphingomyelin phosphodiesterase, acid-like 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr20:40,779,022...40,800,842
Ensembl chr20:40,778,927...40,800,868
G
Sparcl1
SPARC like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr14:6,994,261...7,025,309
Ensembl chr14:6,994,190...7,025,308
G
Spink1
serine peptidase inhibitor, Kazal type 1
disease_progression
ISO
protein:increased expression:serum
RGD
PMID:8988701
RGD:2300390
NCBI chr18:38,221,919...38,242,092
Ensembl chr18:38,221,681...38,242,119
G
Srd5a1
steroid 5 alpha-reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21232532 PMID:23183084
NCBI chr 1:36,320,504...36,354,694
Ensembl chr 1:36,320,461...36,354,756
G
Srd5a2
steroid 5 alpha-reductase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21232532
NCBI chr 6:25,279,635...25,315,501
Ensembl chr 6:25,279,626...25,315,511
G
Sst
somatostatin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr11:80,358,172...80,359,449
Ensembl chr11:80,358,211...80,359,444
G
Stc2
stanniocalcin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr10:16,542,909...16,552,675
Ensembl chr10:16,542,882...16,553,295
G
Suclg2
succinate-CoA ligase GDP-forming subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23284138
NCBI chr 4:127,552,100...127,824,970
Ensembl chr 4:127,552,101...127,824,970
G
Sulf2
sulfatase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642 PMID:21063030
NCBI chr 3:162,791,349...162,872,984
Ensembl chr 3:162,791,355...162,872,831
G
Tacstd2
tumor-associated calcium signal transducer 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 4:98,341,187...98,342,887
Ensembl chr 4:98,341,188...98,342,887
G
Tagln
transgelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 8:50,222,895...50,228,369
Ensembl chr 8:50,222,896...50,231,357
G
Tgfb2
transforming growth factor, beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr13:105,039,639...105,142,010
Ensembl chr13:105,039,853...105,141,030
G
Thra
thyroid hormone receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22138541
NCBI chr10:86,657,285...86,684,935
Ensembl chr10:86,657,285...86,684,933
G
Tnc
tenascin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 5:79,789,686...79,874,555
Ensembl chr 5:79,789,671...79,874,671
G
Tnf
tumor necrosis factor
treatment
IDA IEP
protein:increased expression:peritoneal fluid
RGD
PMID:21741153 , PMID:23427178
RGD:7247423 , RGD:10395305
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 Ensembl chr20:5,189,390...5,192,000
G
Tnfrsf1b
TNF receptor superfamily member 1B
treatment
ISO
human protein in rat model
RGD
PMID:21481092 , PMID:21741153
RGD:5131251 , RGD:7247423
NCBI chr 5:163,136,390...163,167,299
Ensembl chr 5:163,136,390...163,167,299
G
Tob1
transducer of ErbB-2.1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr10:81,913,689...81,915,727
Ensembl chr10:81,913,689...81,915,716
G
Trh
thyrotropin releasing hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 4:124,110,716...124,113,242
Ensembl chr 4:124,110,716...124,113,242
G
Txnip
thioredoxin interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 2:198,683,168...198,686,971
Ensembl chr 2:198,683,159...198,686,974
G
Ust
uronyl-2-sulfotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20864642
NCBI chr 1:2,330,631...2,627,654
Ensembl chr 1:2,333,778...2,627,747
G
Vav1
vav guanine nucleotide exchange factor 1
IEP
mRNA:increased expression:endometrium
RGD
PMID:17845203
RGD:2303708
NCBI chr 9:9,617,551...9,675,167
Ensembl chr 9:9,617,786...9,675,110
G
Vcan
versican
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21063030
NCBI chr 2:18,490,102...18,587,340
Ensembl chr 2:18,490,102...18,565,842
G
Vegfa
vascular endothelial growth factor A
IEP
mRNA:increased expression:endometrium
RGD
PMID:20056215
RGD:5135061
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Vip
vasoactive intestinal peptide
ISO
RGD
PMID:18928861
RGD:5685615
NCBI chr 1:42,169,307...42,177,582
Ensembl chr 1:42,169,501...42,177,582
G
Angpt1
angiopoietin 1
ISO
protein:increased expression:endometrium epithelium
RGD
PMID:17295646
RGD:2293852
NCBI chr 7:81,338,327...81,592,459
Ensembl chr 7:81,342,280...81,592,206
G
Angpt2
angiopoietin 2
ISO
protein:increased expression:endometrium epithelium
RGD
PMID:17295646
RGD:2293852
NCBI chr16:75,966,480...76,016,147
Ensembl chr16:75,966,352...76,016,195
G
Arid1a
AT-rich interaction domain 1A
treatment
ISO
human cell in mouse model
RGD
PMID:21900401
RGD:126725086
NCBI chr 5:151,904,687...151,977,973
Ensembl chr 5:151,904,684...151,977,636
G
Axin2
axin 2
ISO
RGD
PMID:11940574
RGD:13432156
NCBI chr10:97,212,483...97,238,824
Ensembl chr10:97,212,432...97,239,642
G
Bet1l
Bet1 golgi vesicular membrane trafficking protein-like
disease_progression
ISO
RGD
PMID:28654152
RGD:14394612
NCBI chr 1:213,602,836...213,606,507
Ensembl chr 1:213,602,850...213,605,643
G
Cd55
CD55 molecule (Cromer blood group)
ISO
RGD
PMID:11506079
RGD:2326173
NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
G
Ebag9
estrogen receptor binding site associated, antigen, 9
ISO
protein:increased expression:endometrium
RGD
PMID:16112719
RGD:2289850
NCBI chr 7:83,564,563...83,582,516
Ensembl chr 7:83,564,563...83,582,508
G
Foxo3
forkhead box O3
severity
ISO
associated with Obesity;protein:decreased expression:endometrium (human)
RGD
PMID:26045339
RGD:11530998
NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
G
Gpx3
glutathione peroxidase 3
IEP
mRNA:decreased expression:endometrium (rat)
RGD
PMID:19426485
RGD:2312621
NCBI chr10:40,247,436...40,255,423
Ensembl chr10:40,247,436...40,255,422
G
Irf1
interferon regulatory factor 1
IAGP
DNA:deletions (rat)
RGD
PMID:19075038
RGD:5128782
NCBI chr10:39,109,530...39,116,532
Ensembl chr10:39,109,522...39,116,531
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
no_association
ISO
RGD
PMID:10684716
RGD:2290482
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Kras
KRAS proto-oncogene, GTPase
IAGP
DNA:point mutation:CDS:p.G12D, p.G12S, p.Q61H (rat)
RGD
PMID:10775052
RGD:1600499
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Mapk1
mitogen activated protein kinase 1
treatment
ISO
human tumor in a mouse model protein:decreased phosphorylation:endometrium (human)
RGD
PMID:23402905 , PMID:14760076
RGD:13703125 , RGD:13703137
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
treatment
ISO
human tumor in a mouse model protein:decreased phosphorylation:endometrium (human)
RGD
PMID:23402905 , PMID:14760076
RGD:13703125 , RGD:13703137
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
DNA:mutations:multiple (human)
RGD
PMID:21478295
RGD:13441595
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Ptges
prostaglandin E synthase
ISO
protein:increased expression:endometrium
RGD
PMID:11592775
RGD:2300089
NCBI chr 3:9,727,408...9,738,752
Ensembl chr 3:9,727,408...9,738,752
G
Rrm2
ribonucleotide reductase regulatory subunit M2
IAGP
DNA:amplification (rat)
RGD
PMID:15942940
RGD:2324953
NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
G
Tgfbr3
transforming growth factor beta receptor 3
ISO
mRNA:decreased expression:endometrium
RGD
PMID:15745937
RGD:1579943
NCBI chr14:3,506,416...3,680,508
Ensembl chr14:3,506,339...3,682,545
G
Tp53
tumor protein p53
disease_progression
ISO
DNA:missense mutations protein:increased expression:endometrium
RGD
PMID:1540970 , PMID:1540970
RGD:2290541 , RGD:2290541
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tsg101
tumor susceptibility 101
ISO
mRNA:alternative forms
RGD
PMID:10027311
RGD:2291854
NCBI chr 1:102,941,151...102,971,017
Ensembl chr 1:102,941,231...102,970,950
G
Adrb3
adrenoceptor beta 3
susceptibility
ISO
associated with Obesity;DNA:polymorphism: :p.W64R (human)
RGD
PMID:15743038
RGD:2313164
NCBI chr16:69,003,541...69,006,632
Ensembl chr16:69,003,868...69,006,632
G
Afp
alpha-fetoprotein
severity
ISO
protein:increased expression:serum
RGD
PMID:17659325
RGD:2292039
NCBI chr14:19,141,755...19,159,919
Ensembl chr14:19,141,755...19,159,923
G
Akt2
AKT serine/threonine kinase 2
severity
ISO
DNA:snp:intron:c.287+993G>A (rs892119) (human)
RGD
PMID:22146979
RGD:13432140
NCBI chr 1:84,400,939...84,451,223
Ensembl chr 1:84,411,726...84,450,162
G
Ang
angiogenin
ISO
protein:increased expression:serum
RGD
PMID:9119882
RGD:2317659
NCBI chr15:28,022,926...28,028,636
G
Apc
APC regulator of WNT signaling pathway
severity treatment
ISO
with Pten knockout protein:increased expression:endometrium (human) DNA:mutations, haplotype:cds:multiple (human) human cells in a mouse model
RGD
PMID:23288720 , PMID:15951972 , PMID:29876005 , PMID:22907428
RGD:13524585 , RGD:13673917 , RGD:13673916 , RGD:13524624
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
ISO
DNA:nonsense mutation, missense mutations: :p.W188X, p.P112L, p.R237C (human)
RGD
PMID:11465542
RGD:2315878
NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
G
Ar
androgen receptor
ISO
RGD
PMID:15721279
RGD:1578689
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
G
Arid1a
AT-rich interaction domain 1A
onset
ISO
protein:decreased expression:endometrium (human)
RGD
PMID:23887303
RGD:126779522
NCBI chr 5:151,904,687...151,977,973
Ensembl chr 5:151,904,684...151,977,636
G
Atm
ATM serine/threonine kinase
susceptibility
ISO
RGD
PMID:17164260
RGD:2293868
NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
G
Bad
BCL2-associated agonist of cell death
disease progression
ISO
protein:altered expression:endometrium (human)
RGD
PMID:24645842
RGD:13432164
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
G
Bag1
BAG cochaperone 1
ISO
protein:increased expression:endometrium
RGD
PMID:15297164
RGD:2293886
NCBI chr 5:57,254,421...57,267,002
Ensembl chr 5:57,254,421...57,267,002
G
Bcl2l1
Bcl2-like 1
ISO
protein:increased expression:endometrium
RGD
PMID:17311011
RGD:1643476
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Brca2
BRCA2, DNA repair associated
ISO
DNA:deletion, frameshift mutation
RGD
PMID:10451700
RGD:2296027
NCBI chr12:503,660...544,754
Ensembl chr12:504,007...544,748
G
Bst2
bone marrow stromal cell antigen 2
treatment
ISO
protein:increased expression:endometrium:
RGD
PMID:26498112 , PMID:22729361 , PMID:22729361
RGD:14398492 , RGD:14398498 , RGD:14398498
NCBI chr16:19,938,781...19,942,353
Ensembl chr16:19,938,784...19,942,353
G
Cd59
CD59 molecule
ISO
protein:increased expression:endometrium
RGD
PMID:10637067
RGD:2293548
NCBI chr 3:94,010,481...94,028,660
Ensembl chr 3:94,010,475...94,028,621
G
Cd9
CD9 molecule
ISO
RGD
PMID:11505398
RGD:2326208
NCBI chr 4:157,977,163...158,010,091
Ensembl chr 4:157,977,162...158,010,166
G
Cdc25b
cell division cycle 25B
ISO
RGD
PMID:14559803
RGD:4105451
NCBI chr 3:123,731,539...123,741,696
Ensembl chr 3:123,731,539...123,741,339
G
Cdc25c
cell division cycle 25C
ISO
DNA:mutation (human)
RGD
PMID:12124347
RGD:4105455
NCBI chr18:27,528,768...27,550,316
Ensembl chr18:27,528,354...27,550,224
G
Cdh1
cadherin 1
ISO
OMIM
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
IAGP
DNA:deletions:exon (rat)
RGD
PMID:18558284
RGD:2316081
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
IAGP
DNA:deletion (rat)
RGD
PMID:18558284
RGD:2316081
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
G
Chi3l1
chitinase 3 like 1
severity
ISO
protein:increased secretion:serum (human)
RGD
PMID:17023034
RGD:4892642
NCBI chr13:51,022,844...51,030,797
Ensembl chr13:51,022,681...51,030,802
G
Comt
catechol-O-methyltransferase
susceptibility no_association
ISO
DNA:hypermethylation:promoter DNA:polymorphism: :p.V158M
RGD
PMID:12810635 , PMID:17442187 , PMID:15285606
RGD:2289723 , RGD:2289714 , RGD:2289721
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISO
DNA:SNP::increase in frequency of mutant heterozygote C/T (p=0.0004)
RGD
PMID:18497059
RGD:2301045
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
RGD
PMID:18318428
RGD:2301040
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
RGD
PMID:18497059
RGD:2301045
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Efemp2
EGF containing fibulin extracellular matrix protein 2
exacerbates ameliorates
ISO
protein:decreased expression:endometrium (human) human EFEMP2 knockdown cell line in a mouse model
RGD
PMID:28177909 , PMID:28177909
RGD:42722012 , RGD:42722012
NCBI chr 1:220,853,695...220,861,420
Ensembl chr 1:220,854,403...220,861,420
G
Egf
epidermal growth factor
severity
ISO
DNA:snps:5'utr:multiple (human)
RGD
PMID:19319135
RGD:13673915
NCBI chr 2:68,820,616...68,895,537
G
Errfi1
ERBB receptor feedback inhibitor 1
ISS
OMIM:608089
MouseDO
NCBI chr 5:167,951,564...167,966,011
Ensembl chr 5:167,952,728...167,966,009
G
Fgf1
fibroblast growth factor 1
disease_progression
ISO
mRNA:increased expression:myometrium
RGD
PMID:8685603
RGD:2298516
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
G
Fgf2
fibroblast growth factor 2
disease_progression
ISO
mRNA, protein:increased expression:myometrium
RGD
PMID:8685603
RGD:2298516
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
G
Fgfr2
fibroblast growth factor receptor 2
ISO
ClinVar Annotator: match by term: Endometrial cancer, somatic
ClinVar
PMID:7719344 PMID:8651276 PMID:9462761 PMID:9719378 PMID:10851026 PMID:11121055 PMID:11390973 PMID:12124745 PMID:14499350 PMID:15975938 PMID:16440883 PMID:17525745 PMID:18552176 PMID:20301628 PMID:21367659 PMID:22238366 PMID:22664175 PMID:23002168 PMID:23495007 PMID:23546041 PMID:24489893 PMID:25157968 PMID:25741868 PMID:25867380 PMID:26380986 PMID:26619011 PMID:28492532 PMID:31145570
NCBI chr 1:200,590,951...200,696,946
Ensembl chr 1:200,590,953...200,696,928
G
Ghrh
growth hormone releasing hormone
ISO
mRNA:increased expression:tumor:expression in 17/22 specimens
RGD
PMID:10022420 , PMID:15784701
RGD:2289974 , RGD:2301423
NCBI chr 3:153,449,124...153,468,794
Ensembl chr 3:153,449,125...153,468,794
G
Hoxb13
homeo box B13
ISO
RGD
PMID:15756448
RGD:2314730
NCBI chr10:84,031,955...84,034,228
Ensembl chr10:84,031,955...84,034,228
G
Htra2
HtrA serine peptidase 2
ISO
protein:decreased expression:endometrium (human)
RGD
PMID:19424634
RGD:5688747
NCBI chr 4:113,883,671...113,886,833
Ensembl chr 4:113,883,670...113,886,994
G
Il10
interleukin 10
ISO
protein:increased expression:serum
RGD
PMID:9119882
RGD:2317659
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Jup
junction plakoglobin
ISO
protein:decreased expression:endometrium
RGD
PMID:12635138
RGD:2301747
NCBI chr10:88,280,517...88,307,451
Ensembl chr10:88,279,632...88,307,412
G
Kras
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Endometrial cancer
ClinVar
PMID:6320174 PMID:11745231 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16618717 PMID:17384584 PMID:18316791 PMID:18794081 PMID:19018267 PMID:19114683 PMID:19255327 PMID:19679400 PMID:19773371 PMID:20921462 PMID:20921465 PMID:21228335 PMID:21975775 PMID:23014527 PMID:23182985 PMID:23406027 PMID:25044103 PMID:25157968 PMID:31666701
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Lta
lymphotoxin alpha
susceptibility
ISO
DNA:polymorphism: :252A>G, 804C>A (human)
RGD
PMID:17045328
RGD:2313259
NCBI chr20:4,851,889...4,854,677
Ensembl chr20:4,852,496...4,854,677
G
Mcph1
microcephalin 1
ISO
DNA:deletions:exons:multiple (human)
RGD
PMID:20638839
RGD:9589018
NCBI chr16:75,904,087...76,110,624
Ensembl chr16:75,904,006...76,110,553
G
Mir21
microRNA 21
ISO
miRNA:increased expression:endometrium
RGD
PMID:33408517
RGD:126775148
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
G
Mlh3
mutL homolog 3
ISO
ClinVar Annotator: match by term: endometrial cancer
OMIM ClinVar
PMID:12702580
NCBI chr 6:109,059,386...109,095,876
Ensembl chr 6:109,059,341...109,095,557
G
Mmp7
matrix metallopeptidase 7
disease_progression
ISO
protein:increased expression:endometrium
RGD
PMID:17352221
RGD:2298522
NCBI chr 8:5,893,253...5,900,965
Ensembl chr 8:5,893,249...5,901,049
G
Mre11
MRE11 homolog, double strand break repair nuclease
ISO
DNA:deletions:intron:IVS4_delT (human)
RGD
PMID:15048091
RGD:2317737
NCBI chr 8:13,304,355...13,350,329
Ensembl chr 8:13,305,152...13,352,489
G
Msh3
mutS homolog 3
ISO
OMIM
NCBI chr 2:21,790,048...21,931,791
Ensembl chr 2:21,790,044...21,931,720
G
Msh6
mutS homolog 6
ISO
ClinVar Annotator: match by term: Endometrial cancer
OMIM ClinVar
PMID:11807791 PMID:15483016 PMID:18301448 PMID:20028993 PMID:20379851 PMID:20487569 PMID:20937110 PMID:23733757 PMID:24323032 PMID:24362816 PMID:25525159 PMID:25741868 PMID:26467025 PMID:26689913 PMID:28492532 PMID:28528518 PMID:29360161 PMID:31658756
NCBI chr 6:11,644,565...11,662,389
Ensembl chr 6:11,644,578...11,662,499
G
Mutyh
mutY DNA glycosylase
ISO
ClinVar Annotator: match by term: endometrial cancer
ClinVar
PMID:11818965 PMID:12606733 PMID:15635083 PMID:15931596 PMID:15987719 PMID:16492921 PMID:16557584 PMID:17489848 PMID:17956577 PMID:18534194 PMID:19032956 PMID:19245865 PMID:19394335 PMID:19732775 PMID:19793053 PMID:19836313 PMID:19953527 PMID:19998059 PMID:20418187 PMID:20848659 PMID:21063410 PMID:21171015 PMID:21178863 PMID:21815886 PMID:21952991 PMID:22158503 PMID:22297469 PMID:22473953 PMID:22703879 PMID:22744763 PMID:22926731 PMID:23035301 PMID:23108399 PMID:23361220 PMID:23561487 PMID:23625202 PMID:23805267 PMID:24033266 PMID:24082139 PMID:24278394 PMID:24444654 PMID:24728327 PMID:24953332 PMID:25741868 PMID:25820570 PMID:26467025 PMID:26822237 PMID:26845104 PMID:27829682 PMID:28492532 PMID:28634180
NCBI chr 5:135,663,328...135,675,348
Ensembl chr 5:135,663,371...135,675,344
G
Notch1
notch receptor 1
ISO
mRNA:increased expression:endometrium
RGD
PMID:11078798
RGD:2299153
NCBI chr 3:3,905,562...3,951,015
Ensembl chr 3:3,905,453...3,951,025
G
Notch4
notch receptor 4
ISO
mRNA:decreased expression:endometrium
RGD
PMID:11078798
RGD:2299153
NCBI chr20:4,329,794...4,353,868
Ensembl chr20:4,329,811...4,353,785
G
Pgm1
phosphoglucomutase 1
ISO
RGD
PMID:508567
RGD:2299870
NCBI chr 5:118,743,632...118,803,055
Ensembl chr 5:118,743,632...118,803,055
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
onset
ISO
mRNA:increased expression:endometrium (human)
RGD
PMID:28002804
RGD:13674181
NCBI chr 8:107,275,849...107,381,088
Ensembl chr 8:107,275,725...107,380,933
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
ISO
RGD
PMID:21478295
RGD:13441595
NCBI chr 5:166,602,053...166,628,028
Ensembl chr 5:166,602,053...166,628,028
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
DNA:mutations:multiple (human)
RGD
PMID:21984976
RGD:13674179
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Pten
phosphatase and tensin homolog
ISS ISO
OMIM:608089 ClinVar Annotator: match by term: Endometrial cancer
MouseDO ClinVar
PMID:10866302 PMID:11504908 PMID:18767981 PMID:20085938 PMID:21824802 PMID:21828076 PMID:25157968 PMID:26619011 PMID:27535533 PMID:29706350
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
G
Runx1
RUNX family transcription factor 1
ISO
mRNA:decreased expression:endometrium
RGD
PMID:33408517
RGD:126775148
NCBI chr11:32,765,147...33,003,061
Ensembl chr11:32,769,165...33,003,021
G
Shbg
sex hormone binding globulin
ISO
DNA:polymorphism:exon:p.D327N (human)
RGD
PMID:17315164
RGD:1625245
NCBI chr10:56,219,861...56,237,354
Ensembl chr10:56,219,858...56,223,245
G
Smad2
SMAD family member 2
ISO
protein:increased expression:endometrium
RGD
PMID:12883738
RGD:2299970
NCBI chr18:72,550,107...72,612,078
Ensembl chr18:72,550,219...72,612,078
G
Smad3
SMAD family member 3
ISO
protein:increased expression:endometrium
RGD
PMID:12883738
RGD:2299970
NCBI chr 8:68,569,530...68,678,349
Ensembl chr 8:68,569,530...68,678,349
G
Smad7
SMAD family member 7
disease_progression
ISO
mRNA:increased expression:endometrium
RGD
PMID:15661223
RGD:2299963
NCBI chr18:71,395,830...71,424,164
Ensembl chr18:71,395,830...71,424,157
G
Socs2
suppressor of cytokine signaling 2
ISO
DNA:hypermethylated
RGD
PMID:15159323
RGD:2298926
NCBI chr 7:36,495,496...36,500,878
Ensembl chr 7:36,495,480...36,499,784
G
Spag9
sperm associated antigen 9
ISO
protein:increased expression:serum:
RGD
PMID:24460345
RGD:30296659
NCBI chr10:81,693,736...81,827,562
Ensembl chr10:81,693,770...81,827,562
G
Stk11
serine/threonine kinase 11
ISO ISS
OMIM:608089
MouseDO
PMID:18245476 , PMID:18245476
RGD:2291944 , RGD:2291944
NCBI chr 7:12,440,751...12,457,513
Ensembl chr 7:12,440,751...12,457,513
G
Sult1a1
sulfotransferase family 1A member 1
ISO
RGD
PMID:16985250
RGD:1581436
NCBI chr 1:198,100,586...198,104,106
Ensembl chr 1:198,100,586...198,104,109
G
Sult1e1
sulfotransferase family 1E member 1
ISO
RGD
PMID:18318428
RGD:2301040
NCBI chr14:22,070,861...22,089,264
Ensembl chr14:22,072,024...22,089,248
G
Tff1
trefoil factor 1
ISO
mRNA, protein:increased expression:endometrium
RGD
PMID:10835496
RGD:2298569
NCBI chr20:9,892,124...9,895,984
Ensembl chr20:9,892,124...9,895,984
G
Timp4
TIMP metallopeptidase inhibitor 4
ISO
mRNA:decreased expression:endometrium
RGD
PMID:15273280
RGD:2290435
NCBI chr 4:147,156,948...147,163,467
Ensembl chr 4:147,156,948...147,163,467
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
protein:increased expression:serum (human)
RGD
PMID:8920779
RGD:5131439
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
protein:increased expression:serum (human)
RGD
PMID:8920779
RGD:5131439
NCBI chr 5:163,136,390...163,167,299
Ensembl chr 5:163,136,390...163,167,299
G
Tp53
tumor protein p53
ISS
OMIM:608089
MouseDO
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tymp
thymidine phosphorylase
ISO
RGD
PMID:18348659
RGD:2293715
NCBI chr 7:130,342,481...130,347,845
Ensembl chr 7:130,342,483...130,347,587
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
ISO
DNA:SNP: :rs2070959 (human)
RGD
PMID:18349273
RGD:2315450
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Wt1
WT1 transcription factor
disease_progression
ISO
RGD
PMID:19443388
RGD:2315542
NCBI chr 3:95,133,221...95,180,574
Ensembl chr 3:95,133,713...95,180,564
G
Abca3
ATP binding cassette subfamily A member 3
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,723,365...13,780,558
Ensembl chr10:13,723,405...13,779,963
G
Apc
APC regulator of WNT signaling pathway
onset
ISO
DNA:hypermethylation:promoter: (human)
RGD
PMID:19900189 , PMID:21363919
RGD:13524625 , RGD:13525011
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
G
Arel1
apoptosis resistant E3 ubiquitin protein ligase 1
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:12702580 PMID:17656264 PMID:22290698 PMID:28492532
NCBI chr 6:108,630,790...108,796,096
Ensembl chr 6:108,635,220...108,796,124
G
Aurka
aurora kinase A
ISO
mRNA, protein:increased expression:endometrium
RGD
PMID:16311121
RGD:2293878
NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
G
Aurkb
aurora kinase B
disease_progression
ISO
mRNA, protein:increased expression:endometrium
RGD
PMID:16311121
RGD:2293878
NCBI chr10:55,625,860...55,632,399
Ensembl chr10:55,626,741...55,634,991
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
DNA:missense mutations, nonsense mutation:cds:multiple (human) ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:16144912
RGD:13432166
NCBI chr 4:67,389,331...67,520,549
Ensembl chr 4:67,396,192...67,520,356
G
Bricd5
BRICHOS domain containing 5
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,839,599...13,841,132
Ensembl chr10:13,839,956...13,841,018
G
Bsg
basigin (Ok blood group)
disease_progression
ISO
protein:increased expression:endometrium
RGD
PMID:17342307
RGD:2296029
NCBI chr 7:12,875,536...12,882,753
Ensembl chr 7:12,875,537...12,882,753
G
Caskin1
CASK interacting protein 1
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,853,107...13,874,254
Ensembl chr10:13,854,339...13,874,254
G
Ccnb1
cyclin B1
ISO
RGD
PMID:17483252
RGD:2289230
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
G
Cd82
Cd82 molecule
disease_progression
ISO
RGD
PMID:12684410
RGD:2289403
NCBI chr 3:82,324,344...82,368,846
Ensembl chr 3:82,324,354...82,368,357
G
Cdh1
cadherin 1
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:8075649 PMID:11598162 PMID:12588804 PMID:14500541 PMID:20233471 PMID:20921021 PMID:22470475 PMID:22703879 PMID:24728327 PMID:25067988 PMID:25637381 PMID:25741868 PMID:25980754 PMID:26182300 PMID:26467025 PMID:27616075 PMID:27720647 PMID:28125075 PMID:28135145 PMID:28352678 PMID:28492532 PMID:30311375
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdh13
cadherin 13
disease_progression
ISO
DNA:hypomethylation
RGD
PMID:18519763
RGD:2298985
NCBI chr19:50,848,793...51,971,618
Ensembl chr19:50,848,736...51,972,103
G
Dhfr
dihydrofolate reductase
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
G
Dnase1l2
deoxyribonuclease 1 like 2
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,812,335...13,814,514
Ensembl chr10:13,812,707...13,814,304
G
E4f1
E4F transcription factor 1
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,812,335...13,835,847
Ensembl chr10:13,815,293...13,826,945
G
Eci1
enoyl-CoA delta isomerase 1
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,797,573...13,810,918
Ensembl chr10:13,797,562...13,810,913
G
Erap1
endoplasmic reticulum aminopeptidase 1
disease_progression
ISO
RGD
PMID:15741767
RGD:2315693
NCBI chr 2:1,410,877...1,449,734
Ensembl chr 2:1,410,934...1,449,733
G
Fgf7
fibroblast growth factor 7
ISO
mRNA:decreased expression:endometrium
RGD
PMID:9070494
RGD:2301091
NCBI chr 3:118,315,859...118,368,464
Ensembl chr 3:118,317,761...118,366,872
G
Fgfr2
fibroblast growth factor receptor 2
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:7719344 PMID:8651276 PMID:8696350 PMID:9462761 PMID:9719378 PMID:10851026 PMID:11121055 PMID:11390973 PMID:12000365 PMID:12124745 PMID:12145519 PMID:12900900 PMID:14499350 PMID:15975938 PMID:16440883 PMID:16531735 PMID:17525745 PMID:18552176 PMID:20301628 PMID:20856019 PMID:21367659 PMID:21397175 PMID:22238366 PMID:22664175 PMID:23002168 PMID:23495007 PMID:23546041 PMID:24489893 PMID:25157968 PMID:25706251 PMID:25741868 PMID:25867380 PMID:25937001 PMID:26380986 PMID:26619011 PMID:27079505 PMID:28492532 PMID:31145570
NCBI chr 1:200,590,951...200,696,946
Ensembl chr 1:200,590,953...200,696,928
G
Fgfr3
fibroblast growth factor receptor 3
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr14:82,272,322...82,287,739
Ensembl chr14:82,273,070...82,287,706
G
Grb2
growth factor receptor bound protein 2
severity
ISO
Shc-Grb2 complex;protein:increased expression:serum (human)
RGD
PMID:22459351
RGD:13441552
NCBI chr10:104,193,953...104,263,071
Ensembl chr10:104,193,955...104,263,071
G
Gsk3b
glycogen synthase kinase 3 beta
severity
ISO
protein:increased expression:endometrium (human)
RGD
PMID:27050373
RGD:13524565
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
G
Hdac3
histone deacetylase 3
disease_progression
ISO
RGD
PMID:18714364
RGD:2306205
NCBI chr18:31,073,057...31,094,347
Ensembl chr18:31,073,058...31,094,303
G
Hras
HRas proto-oncogene, GTPase
disease_progression
ISO
protein:increased expression:endometrial stroma, cytoplasm (human) DNA:snps:cds: (human)
RGD
PMID:9641239 , PMID:8960147
RGD:13441555 , RGD:13781876
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
disease_progression
ISO
RGD
PMID:15800680
RGD:2290481
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Kiss1
KiSS-1 metastasis-suppressor
disease_progression
ISO
mRNA:decreased expression:endometrium
RGD
PMID:15949424
RGD:2302170
NCBI chr13:50,529,506...50,537,603
Ensembl chr13:50,529,510...50,535,389
G
Kras
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:6320174 PMID:11745231 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16474405 PMID:16618717 PMID:16987887 PMID:17056636 PMID:17384584 PMID:17704260 PMID:17875937 PMID:18316791 PMID:18794081 PMID:18958496 PMID:19018267 PMID:19020799 PMID:19114683 PMID:19255327 PMID:19679400 PMID:19773371 PMID:20921462 PMID:20921465 PMID:20949621 PMID:21228335 PMID:21686179 PMID:21784453 PMID:21975775 PMID:23014527 PMID:23182985 PMID:23406027 PMID:23885229 PMID:24033266 PMID:24803665 PMID:25044103 PMID:25157968 PMID:25359213 PMID:25741868 PMID:28492532 PMID:29493581 PMID:31666701
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Mapk1
mitogen activated protein kinase 1
severity
ISO
protein:increased expression:endometrium (human) protein:increased phosphorylation:endometrium (human)
RGD
PMID:29081408 , PMID:22459351
RGD:13702082 , RGD:13441552
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
severity
ISO
protein:increased expression:endometrium (human) protein:increased phosphorylation:endometrium (human)
RGD
PMID:29081408 , PMID:22459351
RGD:13702082 , RGD:13441552
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mir152
microRNA 152
ISO
DNA:hypermethylation
RGD
PMID:21327300
RGD:21066329
NCBI chr10:84,719,319...84,719,403
Ensembl chr10:84,719,319...84,719,403
G
Mlh1
mutL homolog 1
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:12115348 PMID:15133479 PMID:16341804 PMID:16995940 PMID:17510385 PMID:18383312 PMID:18561205 PMID:21056691 PMID:21681552 PMID:22703879 PMID:22736432 PMID:22949387 PMID:24055113 PMID:24728327 PMID:24933000 PMID:25637381 PMID:25741868 PMID:26332594 PMID:26467025 PMID:27600092 PMID:28492532
NCBI chr 8:119,486,655...119,523,716
Ensembl chr 8:119,486,691...119,523,964
G
Mlh3
mutL homolog 3
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:12702580 PMID:17656264 PMID:22290698 PMID:25741868 PMID:28492532
NCBI chr 6:109,059,386...109,095,876
Ensembl chr 6:109,059,341...109,095,557
G
Mlst8
MTOR associated protein, LST8 homolog
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,839,250...13,845,001
Ensembl chr10:13,839,250...13,845,001
G
Mmp8
matrix metallopeptidase 8
ISO
RGD
PMID:10502722
RGD:2306086
NCBI chr 8:5,768,808...5,777,741
Ensembl chr 8:5,768,811...5,778,702
G
Mmp9
matrix metallopeptidase 9
disease_progression
ISO
protein:increased expression:endometrium
RGD
PMID:12487935
RGD:2298523
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Msh3
mutS homolog 3
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:8782829 PMID:25741868 PMID:27476653 PMID:28492532 , PMID:8782829
RGD:1600456
NCBI chr 2:21,790,048...21,931,791
Ensembl chr 2:21,790,044...21,931,720
G
Msh6
mutS homolog 6
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:10471527 PMID:10508506 PMID:10521294 PMID:10537275 PMID:10612827 PMID:11470537 PMID:11709755 PMID:11807791 PMID:11900875 PMID:12019211 PMID:12732731 PMID:14520694 PMID:15098177 PMID:15236168 PMID:15354210 PMID:15483016 PMID:15782118 PMID:15872200 PMID:16203774 PMID:16408224 PMID:16636019 PMID:16813607 PMID:16885385 PMID:17594722 PMID:18033691 PMID:18269114 PMID:18301448 PMID:18566915 PMID:18790734 PMID:19250818 PMID:19389263 PMID:19924528 PMID:20028993 PMID:20176959 PMID:20379851 PMID:20487569 PMID:20937110 PMID:21120944 PMID:22006311 PMID:22102614 PMID:22290698 PMID:22495361 PMID:22703879 PMID:22851212 PMID:22949379 PMID:23047549 PMID:23263490 PMID:23359684 PMID:23523604 PMID:23621914 PMID:23733757 PMID:24033266 PMID:24040339 PMID:24100870 PMID:24323032 PMID:24362816 PMID:24728327 PMID:25006859 PMID:25117503 PMID:25203624 PMID:25231023 PMID:25318681 PMID:25479140 PMID:25525159 PMID:25559809 PMID:25637381 PMID:25741868 PMID:25801821 PMID:25892863 PMID:25980754 PMID:26206375 PMID:26333163 PMID:26467025 PMID:26483394 PMID:26517685 PMID:26530882 PMID:26681312 PMID:26689913 PMID:26720728 PMID:26845104 PMID:26898890 PMID:26901136 PMID:26976419 PMID:27487738 PMID:28125075 PMID:28135145 PMID:28176205 PMID:28323777 PMID:28466842 PMID:28492532 PMID:28528518 PMID:28531214 PMID:28640387 PMID:28767289 PMID:28873162 PMID:29212164 PMID:29360161 PMID:29368341 PMID:29684080 PMID:29887214 PMID:30093976 PMID:30267214 PMID:30612635 PMID:30982232 PMID:31100584 PMID:31391288 PMID:31658756 PMID:32615015 PMID:32773772
NCBI chr 6:11,644,565...11,662,389
Ensembl chr 6:11,644,578...11,662,499
G
Mutyh
mutY DNA glycosylase
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:11818965 PMID:12606733 PMID:16140997 PMID:16338133 PMID:16492921 PMID:16557584 PMID:16616356 PMID:17489848 PMID:17956577 PMID:18414213 PMID:18534194 PMID:19032956 PMID:19245865 PMID:19394335 PMID:19732775 PMID:19793053 PMID:19836313 PMID:19953527 PMID:20418187 PMID:20725929 PMID:20848659 PMID:21063410 PMID:21171015 PMID:21178863 PMID:22266422 PMID:22703879 PMID:22926731 PMID:23035301 PMID:23361220 PMID:23605219 PMID:24033266 PMID:24444654 PMID:24728327 PMID:25741868 PMID:25820570 PMID:26467025 PMID:26845104 PMID:27829682 PMID:28492532
NCBI chr 5:135,663,328...135,675,348
Ensembl chr 5:135,663,371...135,675,344
G
Ncoa1
nuclear receptor coactivator 1
ISO
mRNA:increased expression:endometrium
RGD
PMID:14751175
RGD:2298984
NCBI chr 6:28,677,563...28,931,844
Ensembl chr 6:28,677,540...28,931,843
G
Ncor2
nuclear receptor co-repressor 2
ISO
mRNA:increased expression:endometrium
RGD
PMID:14751175
RGD:2298984
NCBI chr12:36,871,917...37,033,701
Ensembl chr12:36,871,999...37,033,701
G
Nos3
nitric oxide synthase 3
disease_progression
ISO
protein:increased expression:endometrium
RGD
PMID:9276029
RGD:2292090
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
G
Palb2
partner and localizer of BRCA2
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:25741868 PMID:26689913 PMID:26692951 PMID:28492532
NCBI chr 1:192,064,586...192,088,547
Ensembl chr 1:192,064,589...192,088,520
G
Pgp
phosphoglycolate phosphatase
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,836,105...13,838,731
Ensembl chr10:13,836,128...13,838,765
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
DNA:mutations:multiple (human)
RGD
PMID:23636398
RGD:13628733
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Pkd1
polycystin 1, transient receptor potential channel interacting
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,914,057...13,962,008
Ensembl chr10:13,915,214...13,962,008
G
Prkca
protein kinase C, alpha
ISO
RGD
PMID:11371124
RGD:2292462
NCBI chr10:96,186,509...96,585,168
Ensembl chr10:96,191,133...96,584,947
G
Pten
phosphatase and tensin homolog
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
PMID:7728760 PMID:8980400 PMID:9326929 PMID:9740666 PMID:10555148 PMID:10866302 PMID:11504908 PMID:12372056 PMID:18767981 PMID:20085938 PMID:21194675 PMID:21659347 PMID:21824802 PMID:21828076 PMID:21956414 PMID:22703879 PMID:23161105 PMID:23442912 PMID:23555315 PMID:24033266 PMID:24055113 PMID:24728327 PMID:24763289 PMID:25157968 PMID:25186627 PMID:25669429 PMID:25741868 PMID:25980754 PMID:26467025 PMID:26580448 PMID:26619011 PMID:26800850 PMID:27428751 PMID:27477328 PMID:27535533 PMID:28135145 PMID:28492532 PMID:28677221 PMID:29706350 PMID:29785012 PMID:32350270
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
G
Ptgs1
prostaglandin-endoperoxide synthase 1
disease_progression
ISO
RGD
PMID:18416056
RGD:2300125
NCBI chr 3:15,560,685...15,582,339
Ensembl chr 3:15,560,712...15,582,344
G
Ptk2
protein tyrosine kinase 2
severity
ISO
protein:increased expression:endometrium
RGD
PMID:15536334
RGD:2292562
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
G
Rab26
RAB26, member RAS oncogene family
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,894,271...13,898,578
Ensembl chr10:13,893,290...13,898,855
G
Rassf1
Ras association domain family member 1
ISO
DNA, protein:hypermethylation, decreased expression:promoter,
RGD
PMID:18469797
RGD:2299863
NCBI chr 8:116,307,149...116,318,289
Ensembl chr 8:116,307,141...116,318,289
G
Rnps1
RNA binding protein with serine rich domain 1
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,786,339...13,796,720
Ensembl chr10:13,786,459...13,796,717
G
Runx3
RUNX family transcription factor 3
ISO
DNA:hypermethylation:promoter
RGD
PMID:18572225
RGD:2302555
NCBI chr 5:153,507,093...153,531,137
Ensembl chr 5:153,507,093...153,531,137
G
Sfn
stratifin
ISO
RGD
PMID:16271083
RGD:2299931
NCBI chr 5:151,823,422...151,824,937
Ensembl chr 5:151,823,887...151,824,633
G
Smad4
SMAD family member 4
severity
ISO
DNA:substitutions:promoter mRNA:decreased expression:endometrium
RGD
PMID:10331746 , PMID:15385128
RGD:2300009 , RGD:2299966
NCBI chr18:69,626,682...69,657,373
Ensembl chr18:69,627,757...69,671,199
G
Sparc
secreted protein acidic and cysteine rich
ISO
DNA, mRNA, protein:hypermethylation, altered expression
RGD
PMID:17487382
RGD:2300020
NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
G
Tacc3
transforming, acidic coiled-coil containing protein 3
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr14:82,336,283...82,350,069
Ensembl chr14:82,336,324...82,347,679
G
Tff1
trefoil factor 1
disease_progression
ISO
protein:increased expression:endometrium
RGD
PMID:9221798
RGD:2298572
NCBI chr20:9,892,124...9,895,984
Ensembl chr20:9,892,124...9,895,984
G
Timp1
TIMP metallopeptidase inhibitor 1
disease_progression
ISO
protein:increased expression:endometrium
RGD
PMID:12487935
RGD:2298523
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
G
Timp2
TIMP metallopeptidase inhibitor 2
disease_progression
ISO
mRNA:decreased expression:endometrium
RGD
PMID:17009991
RGD:2290360
NCBI chr10:107,338,465...107,386,072
Ensembl chr10:107,338,465...107,386,072
G
Timp4
TIMP metallopeptidase inhibitor 4
disease_progression
ISO
protein:increased expression:endometrium
RGD
PMID:12798711
RGD:2290420
NCBI chr 4:147,156,948...147,163,467
Ensembl chr 4:147,156,948...147,163,467
G
Tp53
tumor protein p53
severity
ISO IMP
protein:increased expression:epithelial cell, endometrium DNA:mutations: :
RGD
PMID:18431720 , PMID:26353976
RGD:2298525 , RGD:11075084
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Traf7
TNF receptor associated factor 7
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,874,444...13,893,090
Ensembl chr10:13,874,456...13,892,997
G
Tsc2
TSC complex subunit 2
ISO
ClinVar Annotator: match by term: Endometrial carcinoma
ClinVar
NCBI chr10:13,962,006...13,996,684
Ensembl chr10:13,961,947...13,996,584
G
Wnt2
Wnt family member 2
ISO
mRNA:decreased expression:endometrium
RGD
PMID:9099960
RGD:2291875
NCBI chr 4:45,286,845...45,332,899
Ensembl chr 4:45,292,437...45,332,420
G
Wnt3
Wnt family member 3
ISO
RGD
PMID:9099960
RGD:2291875
NCBI chr10:91,830,709...91,874,907
Ensembl chr10:91,830,654...91,874,793
G
Wnt4
Wnt family member 4
ISO
RGD
PMID:9099960
RGD:2291875
NCBI chr 5:155,649,238...155,668,065
Ensembl chr 5:155,649,217...155,672,579
G
Wnt5a
Wnt family member 5A
ISO
RGD
PMID:9099960
RGD:2291875
NCBI chr16:4,469,451...4,490,271
Ensembl chr16:4,469,468...4,489,860
G
Brca2
BRCA2, DNA repair associated
susceptibility
ISO
DNA:deletion: :6174delT
RGD
PMID:16650962
RGD:2289045
NCBI chr12:503,660...544,754
Ensembl chr12:504,007...544,748
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
RGD
PMID:17367465
RGD:2292170
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
G
Akt1
AKT serine/threonine kinase 1
ISO
ClinVar Annotator: match by term: Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation
ClinVar
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:26619011 PMID:28492532
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Apc
APC regulator of WNT signaling pathway
ISO
DNA:hypermethylation: (human)
RGD
PMID:18570730
RGD:13432144
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
G
Areg
amphiregulin
ISO
mRNA, protein:increased expression:endometrium
RGD
PMID:16962163
RGD:2289950
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
G
Atp7b
ATPase copper transporting beta
disease_progression
ISO
protein:increased expression:endometrium
RGD
PMID:15790435
RGD:2298864
NCBI chr16:74,865,516...74,944,935
Ensembl chr16:74,865,516...74,945,286
G
Birc5
baculoviral IAP repeat-containing 5
ISO
protein:increased expression:endometrium
RGD
PMID:16803539
RGD:2298940
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Bmp4
bone morphogenetic protein 4
ISO
RGD
PMID:12782598
RGD:2296026
NCBI chr15:20,776,060...20,791,013
Ensembl chr15:20,776,054...20,822,740
G
Ca9
carbonic anhydrase 9
ISO
protein:altered localization:membrane, endometrium
RGD
PMID:17452774
RGD:2298945
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
G
Ccne1
cyclin E1
ISO
protein:increased expression:endometrium
RGD
PMID:17483252
RGD:2289230
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
G
Cdh1
cadherin 1
ISO
protein:decreased expression:endometrium
RGD
PMID:18295959
RGD:2296045
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdk2
cyclin dependent kinase 2
severity
ISO
RGD
PMID:9673386
RGD:2298990
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
ISO
RGD
PMID:17985331
RGD:2299091
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
G
Chek2
checkpoint kinase 2
susceptibility
ISO
RGD
PMID:17164260
RGD:2293868
NCBI chr12:51,845,574...51,878,098
Ensembl chr12:51,845,796...51,877,624
G
Ctnnb1
catenin beta 1
ISO
DNA:mutations
RGD
PMID:17418409
RGD:2289817
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
G
Daxx
death-domain associated protein
ISO
protein:increased expression:ovary:
RGD
PMID:23539629
RGD:9587820
NCBI chr20:5,480,103...5,485,962
Ensembl chr20:5,480,103...5,485,926
G
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:uterus:
RGD
PMID:15721400
RGD:9588596
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
G
Dnmt3b
DNA methyltransferase 3 beta
ISO
mRNA,protein:increased expression:uterus:
RGD
PMID:15721400
RGD:9588596
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
G
Egfr
epidermal growth factor receptor
ISO
mRNA:decreased expression:endometrium ClinVar Annotator: match by term: Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation
ClinVar
PMID:22885469 , PMID:16962163
RGD:2289950
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Eno2
enolase 2
ISO
RGD
PMID:18156975
RGD:2293737
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047 Ensembl chr 9:157,285,179...157,294,047
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
RGD
PMID:16962163
RGD:2289950
NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
RGD
PMID:16962163
RGD:2289950
NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
RGD
PMID:16962163
RGD:2289950
NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644
G
Esr1
estrogen receptor 1
severity
ISO
protein:increased phosphorylation
RGD
PMID:14559803
RGD:4105451
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Fgfr2
fibroblast growth factor receptor 2
ISO
ClinVar Annotator: match by term: Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation
ClinVar
PMID:7719344 PMID:8651276 PMID:9462761 PMID:9719378 PMID:10851026 PMID:11121055 PMID:11390973 PMID:12124745 PMID:14499350 PMID:15975938 PMID:16440883 PMID:17525745 PMID:18552176 PMID:20301628 PMID:21367659 PMID:22238366 PMID:22664175 PMID:23002168 PMID:23495007 PMID:23546041 PMID:23908597 PMID:24489893 PMID:25157968 PMID:25741868 PMID:25867380 PMID:26380986 PMID:26619011 PMID:28492532 PMID:31145570 , PMID:17525745
RGD:2289862
NCBI chr 1:200,590,951...200,696,946
Ensembl chr 1:200,590,953...200,696,928
G
Igfbp3
insulin-like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:17952116
RGD:2301465
NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
G
Inha
inhibin subunit alpha
ISO
RGD
PMID:17143484
RGD:2290368
NCBI chr 9:82,700,482...82,703,383
Ensembl chr 9:82,700,468...82,703,400
G
Inhba
inhibin subunit beta A
ISO
protein:decreased expression:endometrium
RGD
PMID:16423381
RGD:2301688
NCBI chr17:51,894,869...51,919,998
Ensembl chr17:51,898,217...51,912,496
G
Kdr
kinase insert domain receptor
severity
ISO
RGD
PMID:16557278
RGD:2291929
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Kras
KRAS proto-oncogene, GTPase
ISO
associated with Ovarian Neoplasms
RGD
PMID:19542870
RGD:2314910
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Lnpep
leucyl and cystinyl aminopeptidase
ISO
associated with Endometrial Neoplasms
RGD
PMID:15218296
RGD:2314922
NCBI chr 1:59,289,392...59,384,540
Ensembl chr 1:59,297,294...59,347,472 Ensembl chr 1:59,297,294...59,347,472
G
Mapk1
mitogen activated protein kinase 1
treatment
ISO
RGD
PMID:24917306
RGD:13441559
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
treatment
ISO
RGD
PMID:24917306
RGD:13441559
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Msln
mesothelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14576474
NCBI chr10:15,119,700...15,129,129
Ensembl chr10:15,119,663...15,125,408
G
Nkx2-1
NK2 homeobox 1
ISO
DNA:hypermethylation
RGD
PMID:17504987
RGD:2290483
NCBI chr 6:77,418,096...77,423,383
Ensembl chr 6:77,418,096...77,421,286
G
Pdgfra
platelet derived growth factor receptor alpha
ISO
protein:decreased expression:ovary
RGD
PMID:15791568
RGD:2298578
NCBI chr14:35,527,926...35,581,130
Ensembl chr14:35,527,927...35,581,031
G
Pdgfrb
platelet derived growth factor receptor beta
ISO
protein:increased expression:ovary
RGD
PMID:15791568
RGD:2298578
NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
ISO
ClinVar Annotator: match by term: Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation
ClinVar
PMID:21984976
NCBI chr16:20,415,109...20,424,982
Ensembl chr16:20,416,432...20,424,980
G
Pten
phosphatase and tensin homolog
ISO
DNA:mutations: :multiple DNA:loss of heterozygosity, mutations:multiple (human)
RGD
PMID:17418409 , PMID:11156411
RGD:2289817 , RGD:12802357
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:16633066
RGD:1581360
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
G
St14
ST14 transmembrane serine protease matriptase
ISO
associated with Ovarian Neoplasms;protein:increased expression:ovary
RGD
PMID:16439987
RGD:2315091
NCBI chr 8:32,240,113...32,280,813
Ensembl chr 8:32,240,133...32,280,869
G
Wif1
Wnt inhibitory factor 1
ISO
mRNA:increased expression:ovary
RGD
PMID:16436637
RGD:2298535
NCBI chr 7:63,094,955...63,165,158
Ensembl chr 7:63,094,911...63,165,159
G
Cd68
Cd68 molecule
ISO
protein:increased expression:peritoneum (human)
RGD
PMID:19136478
RGD:40925932
NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
G
Btk
Bruton tyrosine kinase
disease_progression
ISO
RGD
PMID:31247078
RGD:124715471
NCBI chr X:105,360,922...105,390,580
Ensembl chr X:105,360,922...105,390,580
G
Dnmt1
DNA methyltransferase 1
ISO
protein:increased expression:ectopic endometrium:
RGD
PMID:22572543
RGD:9588664
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
G
Dnmt3a
DNA methyltransferase 3 alpha
ISO
protein:decreased expression:endometrium:
RGD
PMID:22572543
RGD:9588664
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
G
Dnmt3b
DNA methyltransferase 3 beta
ISO
protein:increased expression:ectopic endometrium:
RGD
PMID:22572543
RGD:9588664
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
G
Pou5f1
POU class 5 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18440631
NCBI chr20:3,747,231...3,751,994
Ensembl chr20:3,747,221...3,751,994
G
Cga
glycoprotein hormones, alpha polypeptide
ISO
protein:increased expression:serum
RGD
PMID:2473429
RGD:2293636
NCBI chr 5:50,362,491...50,393,368
Ensembl chr 5:50,381,244...50,393,367
G
Khdc3
KH domain containing 3, subcortical maternal complex member
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hydatidiform mole
CTD ClinVar
PMID:25741868
NCBI chr 8:79,781,941...79,783,845
Ensembl chr 8:79,781,983...79,783,592
G
Mlh1
mutL homolog 1
ISO
DNA, protein:hypermethylation, decreased expression:promoter, mononuclear cytotrophoblast cell
RGD
PMID:15338238
RGD:2293517
NCBI chr 8:119,486,655...119,523,716
Ensembl chr 8:119,486,691...119,523,964
G
Mmp2
matrix metallopeptidase 2
ISO
protein:increased expression:syncytiotrophoblast cell
RGD
PMID:16884384
RGD:2290363
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Msh2
mutS homolog 2
ISO
DNA, protein:hypermethylation, decreased expression:promoter, mononuclear cytotrophoblast cell
RGD
PMID:15338238
RGD:2293517
NCBI chr 6:11,215,951...11,274,916
Ensembl chr 6:11,215,963...11,274,932
G
Ncr1
natural cytotoxicity triggering receptor 1
ISO
ClinVar Annotator: match by term: Hydatidiform mole
ClinVar
PMID:24033266 PMID:25741868
NCBI chr 1:73,178,917...73,226,504
Ensembl chr 1:73,179,013...73,226,777
G
Pdgfrb
platelet derived growth factor receptor beta
ISO
mRNA:increased expression:mononuclear cytotrophoblast cell
RGD
PMID:8504434
RGD:2292200
NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
G
Msh2
mutS homolog 2
ISO
protein:decreased expression:mononuclear cytotrophoblast cell
RGD
PMID:15338238
RGD:2293517
NCBI chr 6:11,215,951...11,274,916
Ensembl chr 6:11,215,963...11,274,932
G
Kir3dl1
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
ISO
ClinVar Annotator: match by term: Hydatidiform mole, recurrent, 1
ClinVar
PMID:19066229 PMID:21507883 PMID:24105752
NCBI chr 1:73,306,564...73,345,009
Ensembl chr 1:73,307,569...73,344,955
G
Ncr1
natural cytotoxicity triggering receptor 1
ISO
ClinVar Annotator: match by term: Hydatidiform mole, recurrent, 1
ClinVar
PMID:11598368 PMID:14756744 PMID:16239310 PMID:16462743 PMID:18039680 PMID:19054016 PMID:19066229 PMID:19246479 PMID:19650864 PMID:21507883 PMID:21659348 PMID:21948117 PMID:22315435 PMID:22361007 PMID:22646272 PMID:23201303 PMID:23354651 PMID:24033266 PMID:24105752 PMID:25082979 PMID:25097207 PMID:25741868 PMID:26956250 PMID:28492532
NCBI chr 1:73,178,917...73,226,504
Ensembl chr 1:73,179,013...73,226,777
G
Khdc3
KH domain containing 3, subcortical maternal complex member
ISO
ClinVar Annotator: match by OMIM:614293 ClinVar Annotator: match by This custom term has been created by RGD curators.
OMIM ClinVar
PMID:11932746 PMID:19246479 PMID:21623199 PMID:21885028 PMID:23125094 PMID:23232697 PMID:24033266
NCBI chr 8:79,781,941...79,783,845
Ensembl chr 8:79,781,983...79,783,592
G
Mei1
meiotic double-stranded break formation protein 1
ISO
ClinVar Annotator: match by term: HYDATIDIFORM MOLE, RECURRENT, 3
OMIM ClinVar
PMID:25741868 PMID:30388401
NCBI chr 7:123,308,041...123,361,391
Ensembl chr 7:123,308,041...123,361,391
G
RGD1563323
similar to hypothetical protein FLJ22531
ISO
ClinVar Annotator: match by term: HYDATIDIFORM MOLE, RECURRENT, 4
OMIM ClinVar
PMID:25741868 PMID:30388401
NCBI chr 1:219,864,108...219,952,143
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all